A child with severe juvenile dermatomyositis treated with ruxolitinib
- PMID: 30335130
- DOI: 10.1093/brain/awy255
A child with severe juvenile dermatomyositis treated with ruxolitinib
Erratum in
-
Erratum.Brain. 2019 Jan 1;142(1):e3. doi: 10.1093/brain/awy286. Brain. 2019. PMID: 30380022 No abstract available.
Comment in
-
Reply: A child with severe juvenile dermatomyositis treated with ruxolitinib.Brain. 2018 Nov 1;141(11):e81. doi: 10.1093/brain/awy256. Brain. 2018. PMID: 30335129 No abstract available.
Comment on
-
JAK inhibitor improves type I interferon induced damage: proof of concept in dermatomyositis.Brain. 2018 Jun 1;141(6):1609-1621. doi: 10.1093/brain/awy105. Brain. 2018. PMID: 29741608